DUBLIN--(BUSINESS WIRE)--The "Stroke Management Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to ResearchAndMarkets.com's offering.
The global stroke management market reached a value of US$ 31.1 Billion in 2021. Looking forward, the publisher expects the market to reach US$ 46.8 Billion by 2027, exhibiting a CAGR of 7.05% during 2021-2027.
Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
Chronic diseases, including hypertension, migraine, diabetes, dyslipidemia, obesity, cardiac diseases, atrial fibrillation, sickle cell, atrial fibrillation, carotid stenosis, and obstructive sleep apnea, are among the leading factors elevating the risk of stroke.
This, in confluence with the increasing prevalence of these diseases among a significant part of the population, represents one of the primary factors escalating the need for stroke management across the globe. A
dditionally, physical inactivity, tobacco use, unhealthy diet and nutrition, and excessive drug and alcohol consumption are other factors influencing the market positively. Apart from this, due to the increasing geriatric population, which is more vulnerable to stroke, there is a rise in the demand for efficient stroke management.
Furthermore, governing bodies of numerous countries are launching public health programs that encourage people to have periodic screening examinations for detecting chronic diseases.
This, in confluence with the rising awareness among individuals about the advantages of early diagnosis and treatment, is leading to market growth. The approval of new and advanced devices and drugs is also creating a favorable outlook for the market.
Key Questions Answered in This Report:
- How has the global stroke management market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the global stroke management market?
- What are the key regional markets?
- What is the breakup of the market based on the type?
- What is the breakup of the market based on the application?
- What is the breakup of the market based on the end user?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global stroke management market and who are the key players?
- What is the degree of competition in the industry?
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being
- Abbott Laboratories
- B. Braun Melsungen AG
- Boston Scientific Corporation
- Bristol-Myers Squibb Company
- Cardinal Health
- General Electric Company
- GlaxoSmithKline plc
- Medtronic plc
- Merck & Co. Inc.
- Siemens Healthineers AG (Siemens AG).
Key Market Segmentation:
Breakup by Type:
- Diagnostics
- Computed Tomography Scan (CT Scan)
- Magnetic Resonance Imaging (MRI)
- Carotid Ultrasound
- Cerebral Angiography
- Electrocardiography
- Echocardiography
- Others
- Therapeutics
- Tissue Plasminogen Activator
- Anticoagulant
- Antiplatelet
- Antihypertensive
Breakup by Application:
- Ischemic Stroke
- Haemorrhagic Stroke
- Others
Breakup by End User:
- Hospitals
- Ambulatory Surgical Centers
- Diagnostic Centers
- Others
Breakup by Region:
North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
For more information about this report visit https://www.researchandmarkets.com/r/rkx68s
